The past, present, and future of pacemaker therapies

Trends in Cardiovascular Medicine

Volumn 25, Issue 8, 2015, Pages 661-673

  Boink, Gerard J J ^a,b   Christoffels, Vincent M ^a   Robinson, Richard B ^c   Tan, Hanno L ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION CHANNEL;

ADRENERGIC SYSTEM; CLINICAL TRIAL (TOPIC); ELECTRONICS; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART PACING; HUMAN; HYPERPOLARIZATION; NONHUMAN; NUCLEAR REPROGRAMMING; PACEMAKER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; BIOLOGICAL RHYTHM; FORECASTING; PHYSIOLOGY; STANDARDS; TRENDS;

ARRHYTHMIAS, CARDIAC; BIOLOGICAL CLOCKS; CARDIAC PACING, ARTIFICIAL; FORECASTING; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 84945476186     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2015.02.005     Document Type: Review

References (54)

1. Kurtz S.M., Ochoa J.A., Lau E., Shkolnikov Y., Pavri B.B., Frisch D., et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol 2010, 33:705-711.
2. Rosen M.R., Robinson R.B., Brink P.R., Cohen I.S. The road to biological pacing. Nat Rev Cardiol 2011, 8:656-666.
3. Hoffa M., Ludwig C. Einige neue versuche uber herzbewegung. Z Rationelle Med 1850, 9:107-144.
4. McWilliam J.A. Fibrillar contraction of the heart. J Physiol 1887, 8:296-310.
5. McWilliam J.A. Electrical stimulation of the heart in man. Br Med J 1889, 1:348-350.
6. Hyman A.S. Resuscitation of the stopped heart by intracardial therapy II. Experimental use of an artificial pacemaker. Arch Intern Med 1932, 50:283.
7. Lidwill MC. Cardiac disease in relation to anaesthesia. Transactions of the third session, Austraiasian Medicai Congress. Sydney (Australia): British Medical Association; 1929. p. 160.
8. Mond H.G., Sloman J.G., Edwards R.H. The first pacemaker. Pacing Clin Electrophysiol 1982, 5:278-282.
9. Furman S., Szarka G., Layvand D. Reconstruction of Hyman's second pacemaker. Pacing Clin Electrophysiol 2005, 28:446-453.
10. Osler W. Stokes-Adams disease. Ann Noninvasive Electrocardiol 2002, 7:79-81. [discussion 78].
11. Zoll P.M. Resuscitation of the heart in ventricular standstill by external electric stimulation. N Engl J Med 1952, 247:768-771.
12. Elmqvist R., Senning A. Implantable pacemaker for the heart. Medical Electronics, Proceedings of the Second International Conference on Medical Electronics 1960, 253-254. Iliffe and Sons, London. C.N. Smyth (Ed.).
13. Furman S., Schwedel J.B. An intracardiac pacemaker for stokes-adams seizures. N Engl J Med 1959, 261:943-948.
14. Harris A., Bluestone R., Busby E., Davies G., Leatham A., Siddons H., et al. The management of heart block. Br Heart J 1965, 27:469-482.
15. Mond H.G., Wickham G.G., Sloman J.G. The Australian history of cardiac pacing: memories from a bygone era. Heart Lung Circ 2012, 21:311-319.
16. Crozier I., Smith W. Modern device technologies. Heart Lung Circ 2012, 21:320-327.
17. Amin A.S., Tan H.L., Wilde A.A. Cardiac ion channels in health and disease. Heart Rhythm 2010, 7:117-126.
18. Edelberg J.M., Aird W.C., Rosenberg R.D. Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J Clin Invest 1998, 101:337-343.
19. Miake J., Marban E., Nuss H.B. Biological pacemaker created by gene transfer. Nature 2002, 419:132-133.
20. Qu J., Plotnikov A.N., Danilo P., Shlapakova I., Cohen I.S., Robinson R.B., et al. Expression and function of a biological pacemaker in canine heart. Circulation 2003, 107:1106-1109.
21. Robinson R.B., Siegelbaum S.A. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 2003, 65:453-480.
22. Bucchi A., Plotnikov A.N., Shlapakova I., Danilo P., Kryukova Y., Qu J., et al. Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemaker. Circulation 2006, 114:992-999.
23. Bakker M.L., Boink G.J.J., Boukens B.J., Verkerk A.O., van den Boogaard M., den Haan A.D., et al. T-box transcription factor TBX3 reprogrammes mature cardiac myocytes into pacemaker-like cells. Cardiovasc Res 2012, 94:439-449.
24. Boink G.J.J., Verkerk A.O., van Amersfoorth S.C., Tasseron S.J., van der Rijt R., Bakker D., et al. Engineering physiologically controlled pacemaker cells with lentiviral HCN4 gene transfer. J Gene Med 2008, 10:487-497.
25. Qu J., Barbuti A., Protas L., Santoro B., Cohen I.S., Robinson R.B. HCN2 overexpression in newborn and adult ventricular myocytes: distinct effects on gating and excitability. Circ Res 2001, 89:E8-E14.
26. Tse H.F., Xue T., Lau C.P., Siu C.W., Wang K., Zhang Q.Y., et al. Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model. Circulation 2006, 114:1000-1011.
27. f blockade. Heart Rhythm 2008, 5:282-288.
28. Kashiwakura Y., Cho H.C., Barth A.S., Azene E., Marban E. Gene transfer of a synthetic pacemaker channel into the heart: a novel strategy for biological pacing. Circulation 2006, 114:1682-1686.
29. Lakatta E.G., DiFrancesco D. What keeps us ticking: a funny current, a calcium clock, or both?. J Mol Cell Cardiol 2009, 47:157-170.
30. Ruhparwar A., Kallenbach K., Klein G., Bara C., Ghodsizad A., Sigg D.C., et al. Adenylate-cyclase VI transforms ventricular cardiomyocytes into biological pacemaker cells. Tissue Eng Part A 2010, 16:1867-1872.
31. f pacemaker current. J Physiol 2007, 582:1195-1203.
32. 2+-dependence to beta-adrenergic stimulation of HCN2 current. J Mol Cell Cardiol 2012, 52:1233-1239.
33. 2+-stimulated adenylyl cyclase AC1 generates efficient biological pacing as single gene therapy and in combination with HCN2. Circulation 2012, 126:528-536.
34. Cingolani E., Yee K., Shehata M., Chugh S.S., Marban E., Cho H.C. Biological pacemaker created by percutaneous gene delivery via venous catheters in a porcine model of complete heart block. Heart Rhythm 2012, 9:1310-1318.
35. + channel isoform preserves normal conduction in a depolarized cardiac syncytium. Cardiovasc Res 2009, 81:528-535.
36. Boink G.J., Duan L., Nearing B.D., Shlapakova I.N., Sosunov E.A., Anyukhovsky E.P., et al. HCN2/SkM1 gene transfer into canine left bundle branch induces stable, autonomically responsive biological pacing at physiological heart rates. J Am Coll Cardiol 2013, 61:1192-1201.
37. Hoogaars W.M., Engel A., Brons J.F., Verkerk A.O., de Lange F.J., Wong L.Y., et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev 2007, 21:1098-1112.
38. Kapoor N., Liang W., Marban E., Cho H.C. Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18. Nat Biotechnol 2013, 31:54-62.
39. Hu Y.F., Dawkins J.F., Cho H.C., Marban E., Cingolani E. Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block. Sci Transl Med 2014, 6:245ra294.
40. Ruhparwar A., Tebbenjohanns J., Niehaus M., Mengel M., Irtel T., Kofidis T., et al. Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothorac Surg 2002, 21:853-857.
41. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004, 22:1282-1289.
42. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
43. Mandel Y., Weissman A., Schick R., Barad L., Novak A., Meiry G., et al. Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior. Circulation 2012, 125:883-893.
44. Chauveau S., Anyukhovsky E.P., Potapova I.S., Binah O., Itskovitz-Eldor J., Naor S., et al. Keratinocyte-derived cardiomyocytes provide in vivo biological pacemaker function. Eur Heart J 2014, 35. [poster number 87170].
45. Jung J.J., Husse B., Rimmbach C., Krebs S., Stieber J., Steinhoff G., et al. Programming and isolation of highly pure physiologically and pharmacologically functional sinus-nodal bodies from pluripotent stem cells. Stem Cell Rep 2014, 2:592-605.
46. Scavone A., Capilupo D., Mazzocchi N., Crespi A., Zoia S., Campostrini G., et al. Embryonic stem cell-derived CD166+ precursors develop into fully functional sinoatrial-like cells. Circ Res 2013, 113:389-398.
47. Plotnikov A.N., Shlapakova I., Szabolcs M.J., Danilo P., Lorell B.H., Potapova I.A., et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation 2007, 116:706-713.
48. Goumans M.J., de Boer T.P., Smits A.M., van Laake L.W., van Vliet P., Metz C.H., et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 2007, 1:138-149.
49. Shlapakova I.N., Nearing B.D., Lau D.H., Boink G.J., Danilo P., Kryukova Y., et al. Biological pacemakers in canines exhibit positive chronotropic response to emotional arousal. Heart Rhythm 2010, 7:1835-1840.
50. Rosen M.R. Gene therapy and biological pacing. N Engl J Med 2014, 371:1158-1159.
51. Morris G.M., D'Souza A., Dobrzynski H., Lei M., Choudhury M., Billeter R., et al. Characterization of a right atrial subsidiary pacemaker and acceleration of the pacing rate by HCN over-expression. Cardiovasc Res 2013, 100:160-169.
52. 2+-atpase in patients with advanced heart failure. Circulation 2011, 124:304-313.
53. LeWitt P.A., Rezai A.R., Leehey M.A., Ojemann S.G., Flaherty A.W., Eskandar E.N., et al. AAV2-gad gene therapy for advanced parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 2011, 10:309-319.
54. Reddy V.Y., Knops R.E., Sperzel J., Miller M.A., Petru J., Simon J., et al. Permanent leadless cardiac pacing: results of the leadless trial. Circulation 2014, 129:1466-1471.